سعر ستيديفوتال 8مجم 30 قرص 2024

Steadyfutal 8 mg (Future Pharmaceutical Industries, Egypt), 30 tablets: betahistine 8 mg, a histamine analogue used for vertigo, tinnitus and hearing loss in Meniere's syndrome.

• Vertigo, tinnitus and hearing loss associated with Meniere's syndromePopulation: Adultselectronic medicines compendium (eMC)

• Common: nausea, dyspepsia, headache. Not known: hypersensitivity reactions including anaphylaxis; mild gastric complaints (vomiting, gastrointestinal pain, abdominal distension, bloating); cutaneous hypersensitivity (angioneurotic oedema, urticaria, rash, pruritus).International label, same formulation · electronic medicines compendium (eMC)

• Phaeochromocytoma.International label, same formulation · electronic medicines compendium (eMC)
• Hypersensitivity to the active substance or any excipient.International label, same formulation · electronic medicines compendium (eMC)

• Caution in patients with a history of peptic ulcer.International label, same formulation · electronic medicines compendium (eMC)
• Clinical intolerance has been seen in a few patients with bronchial asthma; monitor such patients carefully.International label, same formulation · electronic medicines compendium (eMC)

• MAO inhibitors including MAO-B selective (e.g. selegiline)In vitro data indicate inhibition of betahistine metabolism; caution with concomitant use.electronic medicines compendium (eMC)
• AntihistaminesAs a histamine analogue, betahistine may in theory affect the efficacy of antihistamines (or vice versa).electronic medicines compendium (eMC)

• No adequate human data; animal studies do not indicate harmful reproductive effects at clinically relevant exposure. As a precaution it is preferable to avoid betahistine during pregnancy.General active-ingredient information · electronic medicines compendium (eMC)
• Unknown whether excreted in human milk (excreted in rat milk); weigh the importance of the drug to the mother against the benefits of nursing and potential risks to the child.General active-ingredient information · electronic medicines compendium (eMC)

• Betahistine: Partial histamine H1-receptor agonist and H3-receptor antagonist; increases histamine turnover, may increase cochlear and cerebral blood flow and facilitates vestibular compensation.